FOLH1 and breast carcinoma: Regarding the last point, several immunochemistry studies have demonstrated the presence of PSMA in the endothelial cells of tumoral neovasculature [79], and it is well known that several malignancies may express high levels of PSMA, such as breast cancer [80], melanoma [81], non-small-cell lung cancer [82] or lymphoma [83].